ClinicalTrialsFinder
RecruitingPhase 4NCT05076110

Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures

Sponsor

Mayo Clinic

Enrollment

188 participants

Start Date

Apr 7, 2022

Study Type

INTERVENTIONAL

Summary

This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.

Eligibility

Min Age: 16 YearsMax Age: 60 Years

Inclusion Criteria1

  • Scheduled for a primary Hip Arthroscopy at Mayo Clinic (Rochester, MN)

Exclusion Criteria7

  • medical history of known allergies or intolerance to allergies or intolerance to Motrin, Gabapentin, Tylenol, dexamethasone, tramadol, or Robaxin.
  • Substantial alcohol or drug abuse.
  • History of narcotics within 6 months of surgery.
  • Pregnancy.
  • Renal impairment.
  • Peptic ulcer disease.
  • GI bleeding.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGOxycodone

5 mg tablets every 4 hours postoperatively as needed for pain control

DRUGIbuprofen

800 mg three times a day for 2 weeks postoperatively for pain control; not to exceed 3200 mg/day

DRUGGabapentin

300 mg three times a day for 5 days then wean off by day 10 postoperatively

DRUGAcetaminophen

1000 mg three times a day for up to 4 weeks postoperatively for pain control; not to exceed 4 grams per day

DRUGMethocarbamol

500 mg three times a week for 2 weeks postoperatively

Locations(1)

Mayo clinic

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05076110